Amaros Closes Series A Financing, Expands Advisory Board to Accelerate Market Entry of the EvidenceEngine™ Ophthalmic AI Platform

ATHERTON, Calif.--(BUSINESS WIRE)--Amaros Inc. (www.amaros.ai), a leader in ophthalmic intelligence and the developer of AI-powered EvidenceEngine platform, today announced the successful close of its Series A financing. Backed by a select group of new and existing mission-aligned investors, the round validates Amaros' mission to transform fragmented clinical data into real-time, actionable intelligence for eye care. “This funding confirms our core belief that ophthalmology’s most underutilized